Skip to main content
PloS one
SHIV-162P3 infection of rhesus macaques given maraviroc gel vaginally does not involve resistant viruses.
Risk factors associated with increased mortality among HIV infected children initiating antiretroviral therapy (ART) in South Africa.
Immune activation, CD4+ T cell counts, and viremia exhibit oscillatory patterns over time in patients with highly resistant HIV infection.
A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers.
Incidence of malaria and efficacy of combination antimalarial therapies over 4 years in an urban cohort of Ugandan children.
Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV disease.
TLR2-dependent inhibition of macrophage responses to IFN-gamma is mediated by distinct, gene-specific mechanisms.
Human herpesvirus replication and abnormal CD8+ T cell activation and low CD4+ T cell counts in antiretroviral-suppressed HIV-infected patients.
Potent activity of the HIV-1 maturation inhibitor bevirimat in SCID-hu Thy/Liv mice.
Validation of the SCID-hu Thy/Liv mouse model with four classes of licensed antiretrovirals.
